Lemaitre Vascular Inc (LMAT): David B Roberts , President and Director of Lemaitre Vascular Inc sold 1,766 shares on Apr 18, 2016. The Insider selling transaction was reported by the company on Apr 19, 2016 to the Securities and Exchange Commission. The shares were sold at $16.10 per share for a total value of $28,433.66 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Apr 6, 2016, David B Roberts (President and Director) sold 17,444 shares at $15.99 per share price.On Dec 14, 2015, Joseph P Jr Pellegrino (Chief Financial Officer) sold 21,033 shares at $16.01 per share price.Also, On Dec 8, 2015, Peter R Gebauer (President, International OP) sold 12,816 shares at $15.53 per share price.On Nov 24, 2015, Cornelia W Lemaitre (director) sold 41,135 shares at $15.62 per share price.
LeMaitre Vascular Inc: On Monday, Apr 18, 2016 heightened volatility was witnessed in LeMaitre Vascular Inc which led to swings in the share price. The shares opened for trading at $15.91 and hit $16.37 on the upside , eventually ending the session at $16.08, with a gain of 1.07% or 0.17 points. The heightened volatility saw the trading volume jump to 96,033 shares. The 52-week high of the share price is $18.44 and the company has a market cap of $295 M . The 52-week low of the share price is at $8.38.
Company has been under the radar of several Street Analysts.LeMaitre Vascular Inc is Reiterated by Barrington Research to Outperform and the brokerage firm has raised the Price Target to $ 15.50 from a previous price target of $14 .The Rating was issued on Feb 25, 2016.
Currently the company Insiders own 35.7% of LeMaitre Vascular Inc shares according to the proxy statements.In the past twelve weeks, the net percent change held by company insiders has changed by -26.8%.Institutional Investors own 55.43% of LeMaitre Vascular Inc shares.During last six month period, the net percent change held by insiders has seen a change of -5.88%.
LeMaitre Vascular Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company and its subsidiaries develop manufacture and market medical devices and implants used primarily in the field of vascular surgery. The Company’s product lines include valvulotomes balloon catheters carotid shunts biologic patches biologic grafts radiopaque marking tape anastomotic clips remote endarterectomy devices laparoscopic cholecystectomy devices vascular grafts angioscopes and powered phlebectomy devices. The Company develops manufactures and markets vascular devices to address the needs of vascular surgeons. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart including the Expandable LeMaitre Valvulotome the Pruitt F3 Carotid Shunt VascuTape Radiopaque Tape and the XenoSure biologic patch.